AD Pipeline Update: Nektar’s Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Phase 2b Study June 25, 2025
AD Pipeline Watch: Zai Lab’s IL-13/IL-31R Bispecific Antibody Shows Promise in Preclinical Pilot Study June 13, 2025